Find Calcium Acid Phosphate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

0

Canada

0

Australia

0

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

188RELATED EXCIPIENT COMPANIES

296EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 7757-93-9, Calcium phosphate dibasic, Dicalcium phosphate, Calcium phosphate, dibasic, Dibasic calcium phosphate, Phosphoric acid, calcium salt (1:1)
Molecular Formula
CaHO4P
Molecular Weight
136.06  g/mol
InChI Key
FUFJGUQYACFECW-UHFFFAOYSA-L
FDA UNII
L11K75P92J

Calcium Acid Phosphate
1 2D Structure

Calcium Acid Phosphate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
calcium;hydrogen phosphate
2.1.2 InChI
InChI=1S/Ca.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+2;/p-2
2.1.3 InChI Key
FUFJGUQYACFECW-UHFFFAOYSA-L
2.1.4 Canonical SMILES
OP(=O)([O-])[O-].[Ca+2]
2.2 Other Identifiers
2.2.1 UNII
L11K75P92J
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Anhydrous Dibasic Calcium Phosphate

2. Calcium Phosphate (cahpo4)

3. Calcium Phosphate, Dibasic, Anhydrous

4. Dibasic Calcium Phosphate, Anhydrous

5. Monetite

2.3.2 Depositor-Supplied Synonyms

1. 7757-93-9

2. Calcium Phosphate Dibasic

3. Dicalcium Phosphate

4. Calcium Phosphate, Dibasic

5. Dibasic Calcium Phosphate

6. Phosphoric Acid, Calcium Salt (1:1)

7. Secondary Calcium Phosphate

8. Calcium Phosphate (1:1)

9. Dicalcium Orthophosphate

10. Calcium Hydrogen Orthophosphate

11. Monocalcium Acid Phosphate

12. Dicalcium Phosphate Anhydrous

13. Calcium Monohydrogen Phosphate

14. Calciumphosphate,dibasic

15. Calcium Phosphate Dibasic Anhydrous

16. Anhydrous Dibasic Calcium Phosphate

17. Calcium Phosphate,dibasic

18. Mfcd00010909

19. Calcium Phosphate (dibasic)

20. Chebi:32596

21. Ins-341(ii)

22. L11k75p92j

23. Calcium Phosphate, Dibasic, Anhydrous

24. E-341(ii)

25. Biofos

26. Fujicalin S

27. Dicafos An

28. 7557-93-9

29. Anhydrous Emcompress

30. Ipifosc 20

31. A-tab

32. D-glucopyranosiduronicacid, 1-(2,4-dichlorophenyl)ethyl

33. Calcium Acid Phosphate

34. Calcium Dibasic Phosphate

35. Calcium Secondary Phosphate

36. Calcium Phosphate (cahpo4)

37. Monohydrogen Calcium Phosphate

38. Ccris 1337

39. Hsdb 992

40. Cahpo4

41. Calcium Phosphate, Dibasic [jan]

42. Einecs 231-826-1

43. Calcium Hydrogenorthophosphate

44. Calcium Phosphate, Dibasic, Dental Grade

45. Unii-l11k75p92j

46. Calstar (tn)

47. Calcium Monohydrogen Phosphate Anhydrous

48. Calcii Hydrogenophosphas

49. Calcium;hydrogen Phosphate

50. Ec 231-826-1

51. Calcium Monohydrogenphosphate

52. Dicalcium Phosphate, Anhydrous

53. Calcium (as Phosphate,dibasic)

54. Ins No.341(ii)

55. Chembl2107567

56. Dtxsid20872529

57. Dicalcium Phosphate [inci]

58. Phosphoric Acid Calcium Salt

59. Calcium Hydrogen Monophosphate

60. Calcium Hydrogen Phosphate, Anhydrous

61. Akos015965054

62. Calcium Hydrogenorthophosphate Anhydrous

63. Calcium Phosphate, Dibasic [mi]

64. Calcium Phosphate,dibasic [vandf]

65. Calcium Hydrogenorthophosphate, With A Fluorine Content Of Less Than 0,005 Per Cent By Weight On The Dry Anhydrous Product

66. Calcium Phosphate, Dibasic [hsdb]

67. Dibasic Calcium Phosphate Anhydrous

68. Calcium Hydrogen Phosphate Anhydrous

69. Calcium Phosphate Dibasic [who-dd]

70. Calcium Phosphate, Dibasic (99.95%-ca)

71. Phosphorus (as Dicalcium Phosphate)

72. Calcium Phosphate (1:1) [who-ip]

73. Calcium Phosphate Dibasic, 98.0-105.0%

74. Calcium Phosphate, Dibasic Anhydrous

75. Dibasic Calcium Phosphate, Anhydrous (jan)

76. Calcium Phosphate Dibasic, Puriss., 98.0%

77. Ft-0623397

78. Calcium (calcium Phosphate (dibasic))

79. Calcium Hydrogen Phosphate (anhydrous)

80. Calcii Hydrogenophosphas [who-ip Latin]

81. Calcium (as Phosphate,dibasic) [vandf]

82. D03302

83. Anhydrous Dibasic Calcium Phosphate [jan]

84. Calcium Hydrogen Phosphate [ep Monograph]

85. Calcium Phosphate Dibasic Anhydrous, Usp Fcc Pe

86. Calcium Phosphate Dibasic, Usp, 98.0-103.0%

87. Calcium Phosphate, Dibasic, Anhydrous [ii]

88. Q414619

89. Phosphorus (as Dicalcium Phosphate) [vandf]

90. Calcium Hydrogen Phosphate, Anhydrous [who-ip]

91. Anhydrous Dibasic Calcium Phosphate [usp Monograph]

92. Dibasic Calcium Phosphate, Meets Usp Testing Specifications

93. Phosphorus (as Calcium Phosphate,dibasic) [vandf]

94. Calcium Phosphate Dibasic, Puriss. P.a., Anhydrous, >98.5% (kt)

2.4 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 136.06 g/mol
Molecular Formula CaHO4P
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count0
Exact Mass135.9238364 g/mol
Monoisotopic Mass135.9238364 g/mol
Topological Polar Surface Area83.4 Ų
Heavy Atom Count6
Formal Charge0
Complexity46.5
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Therapeutic Uses

USES--EXCELLENT SOURCE OF CALCIUM & PHOSPHORUS DURING PREGNANCY, LACTATION, OR MILD TO MODERATE HYPOCALCEMIA CHARACTERIZED BY LOW DEGREE OF TETANY. ... IF TETANY IS SEVERE, IV CALCIUM MEDICATION IS ADMIN. ... DOSE--1 TO 5 G/DAY IN 2 OR MORE DIVIDED DOSES.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 770


IT IS NOT MARKETED IN SINGLE ENTITY FORM, SO THAT DOSE OF OTHER INGREDIENTS MAY HAVE TO BE CONSIDERED IN ARRIVING @ SUITABLE SCHEDULE. CALCIUM IS BETTER ABSORBED IF TAKEN IN SMALL DOSES @ FREQUENT INTERVALS.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 770


MEDICATION (VET): FOR PREVENTION & TREATMENT OF RICKETS ALONG WITH VITAMIN D THERAPY, & AS NUTRIENT SOURCE OF CALCIUM & PHOSPHORUS IN FEEDSTUFFS. ... OPTIMUM CALCIUM:PHOSPHORUS RATIO IN DIET MUST ALSO BE MAINTAINED.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 71


DIBASIC CALCIUM PHOSPHATE, NATIONAL FORMULARY ... /IS AMONG CMPD/ CLASSIFIED AS NONSYSTEMIC GASTRIC ANTACIDS, BUT THEIR EFFICACY IS LOW & THEY ARE SELDOM EMPLOYED.

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 967


Medication (VET): Has been used as a dietary supplement, and as an antacid.

Budavari, S. (ed.). The Merck Index - Encyclopedia of Chemicals, Drugs and Biologicals. Rahway, NJ: Merck and Co., Inc., 1989., p. 256


4.2 Drug Warning

BECAUSE OF PHOSPHATE CONTENT, IT IS CONTRAINDICATED IN /PERSONS WITH/ HYPOPARATHYROIDISM.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 770


5 Pharmacology and Biochemistry
5.1 Absorption, Distribution and Excretion

... ITS ELEMENTS ARE SLOWLY ABSORBED FROM SMALL INTESTINE.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 71


USDMF

read-more
read-moreread-more

01

Arvo
Not Confirmed

02

Arvo
Not Confirmed

03

Arvo
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWillow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Flag U.S.A
Digital Content Digital Content

Calcium Acid Phosphate

About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...

Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 states as a drug wholesaler and NABP accreditation since 2007, Willow Birch Pharma delivers top-quality products at competitive prices with unparalleled service and regulatory support nationwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDr. Paul Lohmann® provides premium mineral salts backed by 140+ years of innovation, quality manufacturing, and global expertise.

Flag Germany
Digital Content Digital Content

calcium hydrogen phosphate

About the Company : Dr. Paul Lohmann® is a Germany based developer & manufacturer of high quality mineral salts with over 140 years of expertise. The company offers more than 400 salts in over 7,000 ...

Dr. Paul Lohmann® is a Germany based developer & manufacturer of high quality mineral salts with over 140 years of expertise. The company offers more than 400 salts in over 7,000 specifications for the food, nutraceutical, pharmaceutical, cosmetic & industrial sectors. Manufactured in line with international pharmacopoeia & food regulations, the products are tailored to diverse applications. Supported by advanced production, innovation and a global network of offices and partners, Dr. Paul Lohmann® serves customers worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

03

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Calcium Acid Phosphate

About the Company : We can help your company solve the payment problems during the trading from chinese factories. We supply you with OEM from china.We are professsionals with the competitive price an...

We can help your company solve the payment problems during the trading from chinese factories. We supply you with OEM from china.We are professsionals with the competitive price and high quality.We help you with professional regulation affair.We help you on documentation and systematizing quality control with factories. We assist you in purchasing and negotiating with various suppliers from China.We are your reliable tool and Platform around chemical ,pharmaceutical and pharm-bottle . We believe in trust and quality-reputation.
blank

04

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

dicalcium phosphate anhydrous

About the Company : Hindustan Phosphates Pvt. Ltd. was incorporated on 7th May 1990, under the companies Act, 1951 in the state of Madhya Pradesh.The company is promoted by technically qualified entre...

Hindustan Phosphates Pvt. Ltd. was incorporated on 7th May 1990, under the companies Act, 1951 in the state of Madhya Pradesh.The company is promoted by technically qualified entrepreneurs namely Shri Ashok Badjatiya B.E., M.S. (USA) D.B.M. and Shri Vijay Badjatiya M.Com, LLB.The company was incorporated with the main object of manufacture of Dibasic Calcium Phosphate ( DCP ),Tribasic calcium Phosphate ( TCP ) & various other phosphates.The company had started commercial production from 01/07/1993 in the vicinity of 213 - 214, Sector -1, Industrial Area, Pithampur, Distt. Dhar India. The regd. Office is at 515, Milindas Manor, 2 R.
blank

05

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Calcium phosphate dibasic

About the Company : India Phosphate, established in 2007, is a leading processor, exporter, and supplier of high-quality Calcium Phosphate. Known for its purity, accuracy, and cost-effectiveness, our ...

India Phosphate, established in 2007, is a leading processor, exporter, and supplier of high-quality Calcium Phosphate. Known for its purity, accuracy, and cost-effectiveness, our products are manufactured using premium phosphoric acid and rock phosphate sourced from trusted vendors. We are committed to maintaining high standards in production while offering customization to meet client needs. With a focus on quality and affordability, we continue to serve diverse industries, ensuring reliable and efficient solutions for our customers worldwide.
blank

06

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Calcium phosphate dibasic

About the Company : Jost Chemical Co. is a manufacturer of high purity specialty chemicals for the pharmaceutical, nutritional, food, and other specialty markets. As an FDA registered manufacturer tha...

Jost Chemical Co. is a manufacturer of high purity specialty chemicals for the pharmaceutical, nutritional, food, and other specialty markets. As an FDA registered manufacturer that operates under bulk pharmaceutical cGMP's, Jost Chemical produces high quality chemicals with lot-to-lot consistency that meet USP/EP/ACS/FCC specifications and Kosher and Halal certifications where applicable. Jost Chemical offers a broad line of salts including ascorbates, carbonates, citrates, fumarates, gluconates, lactates, malates, nitrates, phosphates, succinates, sulfates, Ultra Pure Low Heavy Metals and JOSTCOTE® Microencapsulated Products.
blank

07

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Calcium Acid Phosphate

About the Company : Nandu Group consisting of Nandu Chemical Industries, Nandu Chemicals Private Limited and Nandu Pharma Private Limited has a diversified product range to serve multiple applications...

Nandu Group consisting of Nandu Chemical Industries, Nandu Chemicals Private Limited and Nandu Pharma Private Limited has a diversified product range to serve multiple applications across several industries. With more than 40 years of experience in the healthcare industry, Nandu is a well-established and reputed manufacturer of Active Pharmaceutical Ingredients (APIs) for IV Solutions, Dialysis, Electrolytes, Ingredients for Pharmaceuticals, Food and Beverages, Cosmetics, Confectioneries and Laboratory Chemicals. Nandu has built its reputation across the globe with technical excellence, pursuit of highest quality and promise of purity.
blank

08

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Calcium Acid Phosphate

About the Company : Nitika Pharmaceutical Specialities was found in 1991 as a small manufacturing unit has grown today into a dynamic production center for a range of products finding applications in ...

Nitika Pharmaceutical Specialities was found in 1991 as a small manufacturing unit has grown today into a dynamic production center for a range of products finding applications in various Industry Verticals. 15 years after its foundation the company has been able to adapt to the fast growing technological changes to have an edge in the global market place.
blank

09

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

calcium hydrogen phosphate

About the Company : QUALITY CHEMICALS, SL is a fine chemicals manufacturer of pure salts (mineral, metallic, organic, etc.), solvents, acids, basis and some organics. Our products are destined to a wi...

QUALITY CHEMICALS, SL is a fine chemicals manufacturer of pure salts (mineral, metallic, organic, etc.), solvents, acids, basis and some organics. Our products are destined to a wide range of industries, among them: pharmaceutical, laboratory reagent, food and cosmetics. Customized synthesis, purification, packaging and labelling are available. All these products are produced under international standards at our two plants, one of which works on GMP conditions. Furthermore, Quality Chemicals develops and manufactures tailored made chemicals on GMP basis, under confidential agreement. We can be your GMP partner!
blank

10

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Calcium Acid Phosphate

About the Company : Skotmark Speciality Chemicals, previously operating under the name Chem-Bond Research and Innovation since 2019, began as a small-scale manufacturing facility producing raw materia...

Skotmark Speciality Chemicals, previously operating under the name Chem-Bond Research and Innovation since 2019, began as a small-scale manufacturing facility producing raw materials for the pharmaceutical, chemical, and food industries. We are an evolving entity within the chemical industry, focused on manufacturing and supplying a range of products while also innovating new solutions tailored to meet customer demands. Skotmark's expertise lies in its ability to formulate and produce a wide range of specialty chemicals, including but not limited to surfactants, polymers, and additives.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Multivitamins; Multivitamins; Calcium hydrogen phosphate

Brand Name : Pikovit

Dosage Form : Coated Tablet

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

Pharmaline

Lebanon
AMWC Asia-TDAC
Not Confirmed
arrow

Pharmaline

Lebanon
arrow
AMWC Asia-TDAC
Not Confirmed

Calcium Acid Phosphate; Vitamin D3

Brand Name :

Dosage Form : Tablet

Dosage Strength : 600MG; 500IU

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Lebanon

blank

01

Pharmaline

Lebanon
AMWC Asia-TDAC
Not Confirmed
arrow

Pharmaline

Lebanon
arrow
AMWC Asia-TDAC
Not Confirmed

Calcium Acid Phosphate; Vitamin D3

Dosage : Tablet

Dosage Strength : 600MG; 500IU

Brand Name :

Approval Date :

Application Number :

Registration Country : Lebanon

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Lubricants & Glidants

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Co-Processed Excipients

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

API Stability Enhancers

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Empty Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more
Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination
The pharmaceutical industry has long recognized the critical role excipients or inactive ingredients play in drug formulation and delivery. Excipients can comprise up to 90 percent of a medicine's total ingredients and serve crucial functions as binders, disintegrants, coatings, preservatives, colors, and flavorings. According to recent market research, the pharmaceutical excipients market was valued at US$ 9.27 billion in 2023. It is growing at a compound annual growth rate (CAGR) of 7.03 percent and is projected to reach US$ 18.48 billion by 2032. The main factors driving market growth is an increased demand for multifunctional excipients, coupled with the expanding use of generic medications. The development in the biologics sector and advancements in nanotechnology are also contributing significantly to market growth. Major excipient providers include BASF, Evonik, Merck KGaA owned MilliporeSigma, Gangwal Healthcare, Roquette Frères, DuPont, Croda International, Seqens, Boai NKY Pharmaceuticals, PMC Isochem, Minakem, Kewpie Corporation, Ashland Global, SPI Pharma, Pfanstiehl, Nanjing Well Pharmaceutical, ICE Pharma, Anhui Ribobay Pharmaceutical and Nippon Fine Chemical.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) WHO, India’s CDSCO tighten regulations; new GMP guidelines implemented to curb contamination Last year, the World Health Organization (WHO) issued a health alert linking at least 300 child deaths in the Gambia, Uzbekistan, and Indonesia to the ingestion of contaminated cough syrups containing unacceptable levels of diethylene glycol (DEG) and ethylene glycol (EG). In response to the tragic events, the WHO released two draft appendices to its guideline on good manufacturing practices (GMPs) for excipients this year. Manufacturers are now required to use suitable risk assessment tools to identify and mitigate potential hazards.  Since India-made cough syrups had been linked to the deaths, India’s drug regulator — Central Drugs Standard Control Organization (CDSCO) — took steps to prevent contamination, and advised drugmakers to only use pharmaceutical-grade excipients from approved sources. Furthermore, the Indian Health Ministry proposed amendments to the Drugs and Cosmetics Rules, 1945 to include details of excipients on drug labels. While listing all excipients on every strip of medicine may be challenging, the ministry suggested mentioning those causing hypersensitivity on the label. Applicants now mandatorily need to submit evidence of stability and safety of excipients. These regulatory developments have significant implications for excipient manufacturers and pharmaceutical companies worldwide. Leading pharmaceutical excipient firms like Gangwal Healthcare, Sigachi Industries, and Nitika Pharmaceuticals are well-positioned to meet these heightened quality and safety standards, given their long-standing commitment to producing high-quality, compliant excipients.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Roquette buys IFF’s pharma unit for US$ 2.85 bn; Evonik opens new spray-drying facility in Darmstadt In a significant industry move, France-based Roquette entered into an agreement to acquire IFF's pharma solutions business in a deal valued at US$ 2.85 billion. This acquisition is set to rebalance family-owned Roquette’s portfolio around health and nutrition. The deal is expected to accelerate Roquette’s growth and significantly strengthen its presence in the excipients market. Evonik has opened a new facility for drying aqueous dispersions of its Eudragit polymers at its site in Darmstadt, Germany. The facility will help Evonik meet increasing demand from drugmakers for its oral drug delivery solutions. The plant uses green energy solutions. The company has also partnered University of Mainz to commercialize a new class of polyethylene glycols (PEG) lipids for nucleic acid delivery. Evonik’s Health Care business has been growing its nucleic acid drug and vaccine delivery portfolio.  Germany’s Johannes Gutenberg University of Mainz was the first to develop randomized polyethylene glycols (rPEGs). This collaboration aims to expand Evonik’s toolbox of technologies for nucleic acid-based medicines, offering an improved immunogenicity profile for lipid nanoparticle carriers used in mRNA vaccines and therapeutics. Asahi Kasei made significant strides in addressing a pressing industry concern that emerged in 2018 when potentially carcinogenic nitrosamine impurities were detected in several pharmaceuticals. Guided by regional authorities, such as the European Medicines Agency and the US Food and Drug Administration, the pharmaceutical industry has been carrying out extensive assessments and research to identify the cause of these impurities. In response to this challenge, Asahi Kasei developed its Ceolus microcrystalline cellulose with extremely low nitrite levels. The Japanese company achieved nitrite concentrations of 0.1 micrograms per gram or less, which is equivalent to 0.1 parts per million (ppm). The company also started full commercial operation of its second manufacturing facility for Ceolus in Japan, enhancing supply capacity and stability. JRS Pharma and Gujarat Microwax opened a state-of-the-art cotton-based croscarmellose sodium plant in Mehsana, Gujarat (India). This facility aims to produce high-quality excipients that meet global standards, potentially reducing India's dependency on imports and boosting its presence in the global excipient market. The Indian excipient industry accounts for less than 1 percent of the global market share.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Seqens to advance innovative polymer; biologics, personalized medicine create demand for specialized excipients Recent industry collaborations highlight the ongoing innovation in novel excipients. France’s Seqens, with over 20 years of polymer development experience, was chosen by Pleryon Therapeutics to advance its leading osteoarthritis candidate – an innovative GMP polymer. This collaboration leverages Seqens’ newly expanded and modernized cGMP plant in Aramon, France, demonstrating the industry’s commitment to investing in advanced manufacturing capabilities for novel excipients.  The rise of biologics and personalized medicine has created a demand for specialized excipients capable of stabilizing complex molecules and enabling targeted drug delivery. Roquette’s launch of Lycagel Flex, a hydroxypropyl pemix for nutraceutical and pharmaceutical softgel capsules, exemplifies this trend. Built on Roquette’s market-first Lycagel pea starch technology, this plant-based alternative to gelatin offers manufacturers the flexibility to customize formulations for a range of production and end-user needs. The innovative pea starch foundation also underscores the industry’s move towards sustainable bio-based excipients. The trend towards patient-centric drug development has also influenced excipient innovation. Excipients that can improve palatability, ease of swallowing, or enable novel dosage forms (such as orally disintegrating tablets) are in high demand. For example, IFF brought a super disintegrant Ac-Di-Sol, that supports faster disintegration and drug dissolution in oral disintegrating tablets, improving patient experience.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Our view The heightened regulatory scrutiny on excipients due to product contamination incidents has created a high risk perception and uncertainty around the regulatory acceptance of novel excipients. That said, novel excipients are central to the development of new drug modalities and therapies. Going forward, sustainability will also become an increasingly important factor in excipient selection and development. As the industry innovates towards biologics, personalized therapies, and patient-centric formulations, the role of high-quality, multifunctional excipients will only grow more vital in ensuring drug stability, bioavailability, and patient compliance. Companies that can navigate the complex regulatory landscape, invest in R&D, and offer high-quality, multifunctional excipients will be well-positioned to succeed in this evolving market.   

Impressions: 4043

https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination

#PharmaFlow by PHARMACOMPASS
12 Sep 2024

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
PharmaCompass
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 7757-93-9 / Calcium Acid Phosphate API manufacturers, exporters & distributors?

Calcium Acid Phosphate manufacturers, exporters & distributors 1

12

PharmaCompass offers a list of Calcium Acid Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Calcium Acid Phosphate manufacturer or Calcium Acid Phosphate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Acid Phosphate manufacturer or Calcium Acid Phosphate supplier.

API | Excipient name

Calcium Acid Phosphate

Synonyms

7757-93-9, Calcium phosphate dibasic, Dicalcium phosphate, Calcium phosphate, dibasic, Dibasic calcium phosphate, Phosphoric acid, calcium salt (1:1)

Cas Number

7757-93-9

Unique Ingredient Identifier (UNII)

L11K75P92J

Biofos Manufacturers

A Biofos manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Biofos, including repackagers and relabelers. The FDA regulates Biofos manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Biofos API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Biofos manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Biofos Suppliers

A Biofos supplier is an individual or a company that provides Biofos active pharmaceutical ingredient (API) or Biofos finished formulations upon request. The Biofos suppliers may include Biofos API manufacturers, exporters, distributors and traders.

click here to find a list of Biofos suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Biofos USDMF

A Biofos DMF (Drug Master File) is a document detailing the whole manufacturing process of Biofos active pharmaceutical ingredient (API) in detail. Different forms of Biofos DMFs exist exist since differing nations have different regulations, such as Biofos USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Biofos DMF submitted to regulatory agencies in the US is known as a USDMF. Biofos USDMF includes data on Biofos's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Biofos USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Biofos suppliers with USDMF on PharmaCompass.

Biofos NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Biofos as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Biofos API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Biofos as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Biofos and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Biofos NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Biofos suppliers with NDC on PharmaCompass.

Biofos GMP

Biofos Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Biofos GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Biofos GMP manufacturer or Biofos GMP API supplier for your needs.

Biofos CoA

A Biofos CoA (Certificate of Analysis) is a formal document that attests to Biofos's compliance with Biofos specifications and serves as a tool for batch-level quality control.

Biofos CoA mostly includes findings from lab analyses of a specific batch. For each Biofos CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Biofos may be tested according to a variety of international standards, such as European Pharmacopoeia (Biofos EP), Biofos JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Biofos USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty